Antibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 67139-1-Ig - Provider product page

- Provider
- Proteintech Group
- Product name
- LOXL2 antibody
- Antibody type
- Monoclonal
- Description
- LOXL2 antibody (Cat. #67139-1-Ig) is a mouse monoclonal antibody that shows reactivity with Human and has been validated for the following applications: IF, WB,ELISA.
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 1H7F1
- Vial size
- 20ul, 150ul
Submitted references β-Catenin mediated TAM phenotype promotes pancreatic cancer metastasis via the OSM/STAT3/LOXL2 axis.
Single-cell dissection of the human blood-brain barrier and glioma blood-tumor barrier.
LOXL2-induced PEAR1 Ser891 phosphorylation suppresses CD44 degradation and promotes triple-negative breast cancer metastasis.
METTL1/WDR4-mediated tRNA m(7)G modification and mRNA translation control promote oncogenesis and doxorubicin resistance.
Depletion of LOXL2 improves respiratory capacity: From air-breathing fish to mammal under hypoxia.
Lysyl oxidase-like 2 inhibitor rescues D-galactose-induced skeletal muscle fibrosis.
Zhang Y, Zhu X, Chen L, Gao T, Chen G, Zhu J, Wang G, Zuo D
Neoplasia (New York, N.Y.) 2025 Feb;60:101096
Neoplasia (New York, N.Y.) 2025 Feb;60:101096
Single-cell dissection of the human blood-brain barrier and glioma blood-tumor barrier.
Xie Y, Yang F, He L, Huang H, Chao M, Cao H, Hu Y, Fan Z, Zhai Y, Zhao W, Liu X, Zhao R, Xiao B, Shi X, Luo Y, Yin J, Feng D, Hugnot JP, Muhl L, Dimberg A, Betsholtz C, Zhang Y, Wang L, Zhang L
Neuron 2024 Sep 25;112(18):3089-3105.e7
Neuron 2024 Sep 25;112(18):3089-3105.e7
LOXL2-induced PEAR1 Ser891 phosphorylation suppresses CD44 degradation and promotes triple-negative breast cancer metastasis.
Shen Y, Yan J, Li L, Sun H, Zhang L, Li G, Wang X, Liu R, Wu X, Han B, Sun X, Liu J, Fan X
The Journal of clinical investigation 2024 Aug 15;134(16)
The Journal of clinical investigation 2024 Aug 15;134(16)
METTL1/WDR4-mediated tRNA m(7)G modification and mRNA translation control promote oncogenesis and doxorubicin resistance.
Wang Z, Yu P, Zou Y, Ma J, Han H, Wei W, Yang C, Zheng S, Guo S, Wang J, Liu L, Lin S
Oncogene 2023 Jun;42(23):1900-1912
Oncogene 2023 Jun;42(23):1900-1912
Depletion of LOXL2 improves respiratory capacity: From air-breathing fish to mammal under hypoxia.
Sun B, Gao J, Yang L, Huang S, Cao X
International journal of biological macromolecules 2022 Jun 1;209(Pt A):563-575
International journal of biological macromolecules 2022 Jun 1;209(Pt A):563-575
Lysyl oxidase-like 2 inhibitor rescues D-galactose-induced skeletal muscle fibrosis.
Wu Y, Wu Y, Yang Y, Yu J, Wu J, Liao Z, Guo A, Sun Y, Zhao Y, Chen J, Xiao Q
Aging cell 2022 Jul;21(7):e13659
Aging cell 2022 Jul;21(7):e13659
No comments: Submit comment
No validations: Submit validation data